Skip to content
747474AAA

Drawing based on the label description. No photo yet.

74 A pill

Pill with imprint 74 A is white, round, 7 mm and has been identified as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 5 Mg,cll 1.25 mg / 1.25 mg / 1.25 mg / 1.25 mg. It is used for ADHD. It is supplied by Alvogen Inc.

Controlled substance: Schedule II

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 5 Mg,cll 1.25 mg / 1.25 mg / 1.25 mg / 1.25 mg

Imprint
74 A
Strength
Amphetamine Aspartate Monohydrate 1.25 mg / Amphetamine Sulfate 1.25 mg / Dextroamphetamine Saccharate 1.25 mg / Dextroamphetamine Sulfate 1.25 mg
Used for
ADHD
Color
White
Shape
Round
Size
7 mm
Score
Breaks into 2 pieces
Form
Tablet
Manufacturer
Alvogen Inc
Drug class
Stimulant (ADHD medicine)
NDC
47781-174, 47781-174-30, 47781-174-05, 47781-174-01

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 5 Mg,cll pills and guides

What is Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 5 Mg,cll used for?

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets, 5 Mg,cll is used for ADHD.

Medicine type
Stimulant (ADHD medicine)
Official uses from the US prescribing label

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.

Attention Deficit Hyperactivity Disorder (ADHD)

A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV®) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. The symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. The symptoms must not be better accounted for by another mental disorder. For the Inattentive Type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful. For the Hyperactive-Impulsive Type, at least six of the following symptoms must have persisted for at least 6 months: fidgeting/squirming; leaving seat; inappropriate running/climbing; difficulty with quiet activities; "on the go;" excessive talking; blurting answers; can't wait turn; intrusive. The Combined Type requires both inattentive and hyperactive-impulsive criteria to be met.

From the FDA-approved label on DailyMed (published Sep 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows 74 A. The parts can be split between the two sides, so turn the pill over and check both.
  • It is white, round, 7 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,cii.

Ingredients

Active: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate

Inactive: Microcrystalline Cellulose, Starch, Corn, Silicon Dioxide, Magnesium Stearate

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.